Agonist-induced changes in the phosphorylation of the myosin- binding subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle.
about
p116Rip decreases myosin II phosphorylation by activating myosin light chain phosphatase and by inactivating RhoAThromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+ sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscleNitric oxide-induced biphasic mechanism of vascular relaxation via dephosphorylation of CPI-17 and MYPT1The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosisRole of serine-threonine phosphoprotein phosphatases in smooth muscle contractilityUnique aspects of the developing lung circulation: structural development and regulation of vasomotor toneMyosin light chain kinase activation and calcium sensitization in smooth muscle in vivoReconstituted human myosin light chain phosphatase reveals distinct roles of two inhibitory phosphorylation sites of the regulatory subunit, MYPT1.Carbachol-induced rabbit bladder smooth muscle contraction: roles of protein kinase C and Rho kinase.Androgens induce nongenomic stimulation of colonic contractile activity through induction of calcium sensitization and phosphorylation of LC20 and CPI-17.Calcium sensitization induced by sodium fluoride in permeabilized rat mesenteric arteries.Unfair competition governs the interaction of pCPI-17 with myosin phosphatase (PP1-MYPT1).Role of PKC and RhoA/ROCK pathways in the spontaneous phasic activity in the rectal smooth muscle.Rho kinase modulates postnatal adaptation of the pulmonary circulation through separate effects on pulmonary artery endothelial and smooth muscle cells.Thromboxane-induced actin polymerization in hypoxic neonatal pulmonary arterial myocytes involves Cdc42 signaling.ROCKs as therapeutic targets in cardiovascular diseasesRegulation of myosin light chain phosphatase and pulmonary arterial relaxation.A novel regulatory mechanism of myosin light chain phosphorylation via binding of 14-3-3 to myosin phosphatase.G(q)-dependent signalling by the lysophosphatidic acid receptor LPA(3) in gastric smooth muscle: reciprocal regulation of MYPT1 phosphorylation by Rho kinase and cAMP-independent PKARelaxation of canine airway smooth muscle.Sphingosine-1-phosphate induced contraction of bladder smooth musclePKC activation increases Ca²⁺ sensitivity of permeabilized lymphatic muscle via myosin light chain 20 phosphorylation-dependent and -independent mechanismsRegulation of smooth muscle contraction by small GTPases.Diversity and plasticity in signaling pathways that regulate smooth muscle responsiveness: Paradigms and paradoxes for the myosin phosphatase, the master regulator of smooth muscle contraction.Protein phosphatases 1 and 2A and their naturally occurring inhibitors: current topics in smooth muscle physiology and chemical biology.Phorbol 12,13-dibutyrate-induced, protein kinase C-mediated contraction of rabbit bladder smooth muscle.Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit: inhibitory effects and occurrence in A7r5 cells.Mechanisms underlying potentiation of endothelin-1-induced myofilament Ca(2+) sensitization after subarachnoid hemorrhage.PHI-1 interacts with the catalytic subunit of myosin light chain phosphatase to produce a Ca(2+) independent increase in MLC(20) phosphorylation and force in avian smooth muscle.Expression of MYPT1, CPI-17 and MLC20 in ileum of neonatal mouse NEC model and its significance.Differences in the mechanism of collagen lattice contraction by myofibroblasts and smooth muscle cells.A mathematical model of airway and pulmonary arteriole smooth muscle.Inhibition of contraction and myosin light chain phosphorylation in guinea-pig smooth muscle by p21-activated kinase 1.Chronic treatment with interleukin-1beta attenuates contractions by decreasing the activities of CPI-17 and MYPT-1 in intestinal smooth muscle.Gq/G13 signaling by ET-1 in smooth muscle: MYPT1 phosphorylation via ETA and CPI-17 dephosphorylation via ETB.Convergence of Ca2+-desensitizing mechanisms activated by forskolin and phenylephrine pretreatment, but not 8-bromo-cGMP.Chronic hypoxia augments protein kinase G-mediated Ca2+ desensitization in pulmonary vascular smooth muscle through inhibition of RhoA/Rho kinase signaling.Alpha1-adrenoceptor-mediated phosphorylation of MYPT-1 and CPI-17 in the uterine artery: role of ERK/PKC.Activation of Rho-associated kinase during augmented contraction of the basilar artery to serotonin after subarachnoid hemorrhage.
P2860
Q24315196-56454A82-AAE7-4D43-A8C4-9252CC416FD1Q24532856-6D7D5700-EAC6-4844-8B4F-AC834CAF2D20Q24646740-86A0855B-8CD4-44D1-8C17-E4DF4D164BDDQ24656438-3576C7C3-9333-42C9-A7D7-0436CD6157A3Q27005980-8E076AEB-D115-485F-B7DE-3C9E740F5B9FQ27693957-3C75EF67-9B6F-43D3-AE6E-AA7F58F2C0D2Q28076917-9204F64E-C9FE-4D36-91A2-6B7867C5FFE4Q28507897-6D2F0598-A7D4-4691-A9EE-A25330145C20Q30405862-278ED826-32C9-46FE-BE81-8AC56BAFA548Q33570037-9203DD8C-4F6A-40BC-8A09-3D0E10046A27Q33637557-AE034B34-CAEC-4290-9168-3B4F494769ECQ33717185-92A2CB8F-1AAF-4B3A-9360-BB5C4879D9B0Q33719596-825E42A1-C397-4232-8FED-4E42237CA030Q33816566-E39D1C43-F19E-4E10-A176-B6EFBF6C9FEAQ34426112-38198200-2D15-46FC-A1B6-05DE22818E99Q35301117-FFA63F97-7539-4588-B975-69FEA50D211CQ36124892-C5F0BF37-5C5E-4965-B08D-394119041E87Q36333429-75A1B261-8A52-480E-A170-CD3DFE5307F3Q36489049-C56EB7BF-F48C-4634-95C2-44AC296756A9Q36915971-19C9563D-28B8-4565-B942-798CCD644E8FQ36933213-9623BE85-19BD-4061-9B3E-A135BC1AB4A3Q37361115-139876DE-AE90-49F6-BF4D-BD0C551796F7Q37629274-1BA0DE6D-1220-4854-A419-092F0E895167Q37649264-96FF6FC7-DEE2-46CE-BFBA-B0D3D96955DAQ39162238-63222D3E-A9D9-41EC-BDE0-562AB33B917DQ39417427-66CE9E98-2F5A-4813-A66D-CA71A73B9782Q40092633-2BA08DD7-6AFC-4FA4-800A-999AB2443BB5Q40349616-49714D1E-269C-40E5-B5AB-BF7F4CC620D2Q40860386-316970BA-2039-43F8-9121-B2812D29EBD2Q41096126-E2A351EC-6081-4E94-A734-B64C042E7B91Q41672266-61C6C0B0-DF05-4FBD-B2AC-356E889EAA8BQ41877170-C3CB3A60-1F97-43EC-BB83-30260442CC3EQ42872499-ECE79872-CB28-4BA9-9B26-63FACCB57E45Q44401240-362DB0F8-28C2-4AE7-9E51-CAB215504BB1Q44598316-C7C80CAB-762D-49C6-B282-160359DB7CBEQ44905666-36DC23CF-E3C1-4A46-BEED-64344CE303C0Q44916652-72E709B0-A39E-4392-901F-C264CB7E50F3Q45017969-ADC9CC51-4F94-4554-8A83-1115D5F982ECQ45234457-11A25446-500D-463B-B883-6B42F0DCB50CQ45234466-1CCAEED0-8E60-4CFC-9162-75CE4D3C78AC
P2860
Agonist-induced changes in the phosphorylation of the myosin- binding subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Agonist-induced changes in the ...... phosphatase, in smooth muscle.
@en
type
label
Agonist-induced changes in the ...... phosphatase, in smooth muscle.
@en
prefLabel
Agonist-induced changes in the ...... phosphatase, in smooth muscle.
@en
P2093
P2860
P356
P1433
P1476
Agonist-induced changes in the ...... phosphatase, in smooth muscle.
@en
P2093
Mitsuo Ikebe
Naohisa Niiro
Yasuhiko Koga
P2860
P304
P356
10.1042/BJ20021040
P407
P577
2003-01-01T00:00:00Z